![Michael Varney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Varney
Chief Tech/Sci/R&D Officer at
ERASCA, INC.
Net worth: - $ as of 31/05/2026
Profile
Michael D.
Varney currently serves as Director, Chairman-Research & Development at Erasca, Inc. since 2020.
He is Lead Independent Director at Numerion Labs, Inc. starting in 2025.
He holds the position of Director at Affini-T Therapeutics, Inc. since 2022.
He is a Senior Advisor at Frazier Management LLC since 2020.
He is also a Trustee at The California Academy of Sciences.
Formerly, Dr. Varney was Director at Foundation Medicine, Inc. from 2015 to 2018.
He was Independent Director at Pardes Biosciences, Inc. from 2021 to 2023.
He served as Head-Research at Agouron Pharmaceuticals LLC from 1987 to 2005.
He was Executive VP, Head-Research & Early Development at Genentech, Inc. from 2015 to 2020.
He held the role of Head-Genentech Research & Early Development at Roche Holding AG.
He was Vice President-Drug Discovery at Pfizer (St. Louis) from 2000 to 2005.
Dr. Varney completed undergraduate studies at the University of California, Los Angeles in 1980 and earned a doctorate from the California Institute of Technology in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ERASCA, INC. -.--% | 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Michael Varney active positions
| Companies | Position | Start |
|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
The California Academy of Sciences
 The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Director/Board Member | - |
Atomwise, Inc.
 Atomwise, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence platform that explores the vast universe of chemical space to discover novel and drug-like molecules | Director/Board Member | 17/06/2021 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Consultant / Advisor | 01/01/2020 |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Director/Board Member | 05/04/2022 |
Former positions of Michael Varney
| Companies | Position | End |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Director/Board Member | 30/08/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | 01/07/2020 |
| FOUNDATION MEDICINE INC | Director/Board Member | 01/03/2018 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Chief Tech/Sci/R&D Officer | 01/01/2005 |
| ░░░░░░ ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Michael Varney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The California Academy of Sciences
The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a scientific and cultural institution | Commercial Services |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Atomwise, Inc.
Atomwise, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence platform that explores the vast universe of chemical space to discover novel and drug-like molecules | Technology Services |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
- Stock Market
- Insiders
- Michael Varney
